Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17Psilocybin for Fear of Cancer RecurrenceSupportive Care in Cancer · 2026-08-01Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant DepressionClinicalTrials.gov · 2026-07-30Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.JAMA psychiatry · 2026-07-01Psychedelics as a potential treatment for borderline personality disorder: A narrative review.Psychiatry research · 2026-07-01Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-06-01Human brain changes after first psilocybin useNature Communications · 2026-05-05Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal CortexhBiological Psychiatry · 2026-05-01Effects of psychedelic use on authoritarian attitudes revisited.Journal of psychopharmacology (Oxford, England) · 2026-05-01An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.ACS pharmacology & translational science · 2026-03-13The combination of exercise and psychedelics for the treatment of major depressive disorder.Discover mental health · 2026-03-07Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-03-01[Pharmacological post-acute treatment of alcohol use disorder: Established strategies and innovative approaches].Therapeutische Umschau. Revue therapeutique · 2026-02-01Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.Journal of affective disorders · 2026-01-15Mechanisms of psilocybin on the treatment of posttraumatic stress disorder.Journal of psychopharmacology (Oxford, England) · 2026-01-01Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study.Journal of addiction medicine · 2026-01-01Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.General hospital psychiatry · 2026-01-01Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.Journal of affective disorders · 2025-12-15Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2025-12-01A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying LensPsychoactives · 2025-11-14A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?ClinicalTrials.gov · 2025-10-29Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.Pilot and feasibility studies · 2025-10-28Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2025-10-01Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2025-09-01Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed NeuroimagingbioRxiv · 2025-07-03Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-07-01Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Psychiatry research · 2025-07-01Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.Brain and behavior · 2025-07-01Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic ExperienceBrain and Behavior · 2025-06-30Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.BMJ open · 2025-04-15188. Mapping Psilocybin Therapy: A Systematic Review of Therapeutic Frameworks, Adaptations, and Standardization Across Contemporary Clinical TrialsBiological Psychiatry · 2025-04-09194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-09187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-09186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-0958. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-09323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study ParticipationBiological Psychiatry · 2025-04-09Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with DepressionbioRxiv · 2025-03-10Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Brain changes associated with depression treatment: a meta-analysis.NeuroImage. Clinical · 2025-01-01Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.Frontiers in psychology · 2025-01-01Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.Frontiers in psychiatry · 2025-01-01Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Therapeutic advances in psychopharmacology · 2025-01-01Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.Therapeutic advances in psychopharmacology · 2025-01-01Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexitybioRxiv · 2024-12-22Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-07Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional propertiesNature Mental Health · 2024-10-14Human brain changes after first psilocybin usebioRxiv · 2024-10-14Memory, trauma, and self: Remembering and recovering from sexual abuse in psychedelic-assisted therapyJournal of Psychedelic Studies · 2024-10-09A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-19Psychedelic-assisted psychotherapy: where is the psychotherapy research?Psychopharmacology · 2024-08-01Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.Journal of psychiatric research · 2024-08-01Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.Trials · 2024-07-03Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.Journal of affective disorders · 2024-06-15Co-administration of midazolam and psilocybin: Differential effects on subjective quality versus memory of the psychedelic experiencebioRxiv · 2024-06-13A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.Journal of affective disorders · 2024-04-01Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-07Psychedelics and sexual functioning: a mixed-methods study.Scientific reports · 2024-02-07Will Psilocybin-Assisted Therapy Reduce the Incidence of Medical Assistance in Dying?Journal of palliative medicine · 2024-02-01Psychedelics: The New Kid on the BlockAnnals of Indian Psychiatry · 2024-01-01Is Poorly Assisted Psilocybin Treatment an Increasing Risk?The American journal of psychiatry · 2024-01-01Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Journal of psychoactive drugs · 2024-01-01Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.Psychiatry research · 2023-11-01Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.BJPsych open · 2023-07-25A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocolEuropean psychiatry: the journal of the Association of European Psychiatrists · 2023-07-19In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.Science advances · 2023-06-16Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depressionmedRxiv · 2023-06-03Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience.bioRxiv: the preprint server for biology · 2023-05-12Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.The American journal of psychiatry · 2023-05-01High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybinbioRxiv · 2023-04-14Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put FirstPsychiatric News · 2023-02-16The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.Journal of psychoactive drugs · 2023-01-01The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2023-01-01Body mass index (BMI) does not predict responses to psilocybin.Journal of psychopharmacology (Oxford, England) · 2023-01-01Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.Journal of psychopharmacology (Oxford, England) · 2023-01-01Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.Psychopharmacology · 2023-01-01Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.Frontiers in psychiatry · 2023-01-01Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.Contemporary clinical trials · 2022-12-01The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-11-01A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive EmergencyJournal of the American Society of Nephrology · 2022-10-31Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.Nature communications · 2022-10-03Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2022-10-01A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.CNS drugs · 2022-10-01Brain dynamics predictive of response to psilocybin for treatment-resistant depressionResearch Square · 2022-09-20Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych open · 2022-09-06Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.NeuroImage · 2022-08-01Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter LandscapebioRxiv · 2022-07-13Brain dynamics predictive of response to psilocybin for treatment-resistant depressionbioRxiv · 2022-07-04The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Psychiatry research · 2022-07-01Increased global integration in the brain after psilocybin therapy for depression.Nature medicine · 2022-04-01Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?Psychiatric News · 2022-03-24Increased low-frequency brain responses to music after psilocybin therapy for depressionbioRxiv · 2022-02-15Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.Current topics in behavioral neurosciences · 2022-01-01Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.CNS drugs · 2022-01-01Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives.Frontiers in pharmacology · 2022-01-01Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.Network neuroscience (Cambridge, Mass.) · 2022-01-01A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Journal of clinical psychopharmacology · 2022-01-01Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?Frontiers in psychiatry · 2022-01-01P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to musicEuropean Neuropsychopharmacology · 2021-12-01Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational psychiatry · 2021-11-08Registered clinical studies investigating psychedelic drugs for psychiatric disorders.Journal of psychiatric research · 2021-07-01Decreased brain modularity after psilocybin therapy for depression.Research Square · 2021-05-20LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theorybioRxiv · 2021-05-17The emerging role of psilocybin and MDMA in the treatment of mental illness.Expert review of neurotherapeutics · 2020-12-01Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020-07-02Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.Journal of psychopharmacology (Oxford, England) · 2020-06-01Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortexbioRxiv · 2020-05-03Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2020-02-01P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depressionEuropean Neuropsychopharmacology · 2019-12-01Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.NeuroImage · 2019-10-01Psychedelic microdosing benefits and challenges: an empirical codebook.Harm reduction journal · 2019-07-10Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.Progress in neuro-psychopharmacology & biological psychiatry · 2019-06-08Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.Psychopharmacology · 2019-02-01Serotonergic Psychedelics LSD & Psilocybin Increase the Fractal Dimension of Cortical Brain Activity in Spatial and Temporal DomainsbioRxiv · 2019-01-11Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosersPsyArXiv · 2018-11-02Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosersPsyArXiv · 2018-11-02Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.Neuropharmacology · 2018-11-01Effects of psilocybin therapy on personality structure.Acta psychiatrica Scandinavica · 2018-11-01Altered trajectories in the dynamical repertoire of functional network states under psilocybinbioRxiv · 2018-07-25The hidden therapist: evidence for a central role of music in psychedelic therapy.Psychopharmacology · 2018-02-01Psychedelics, Meditation, and Self-Consciousness.Frontiers in psychology · 2018-01-01Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific reports · 2017-10-13Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.Frontiers in pharmacology · 2017-01-01Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.Human brain mapping · 2015-08-01The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.Frontiers in human neuroscience · 2014-01-01Current Research on the Human Experience of Spirituality Following the Ingestion of ‘Magic’ Psilocybin Mushrooms: An Annotated Bibliography for Social Workers and Other Health Care ProfessionalsSSRN Electronic Journal · 2009-12-31A characteristic effect of hallucinogens on investigatory responding in rats.Psychopharmacology · 1979-09-01The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.The Journal of pharmacology and experimental therapeutics · 1978-12-01Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.Psychopharmacologia · 1971-12-30Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects.The Journal of nervous and mental disease · 1960-11-01